Earningsreport

Q4/2025 12/31/2025 EPS -0.270 ZacksConsensus -0.140 ActVsEst (0.130) - Miss

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com